Revisiting a robust biosimilars market and following next steps towards improving biosimilars access and uptake
The Biosimilars industry is experiencing significant growth due to the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness.
The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keeps adding to the hinderance in their development.
MarketsandMarkets Biosimilars- Digital Conference presents to you a virtual platform to keep your scientific exchange live. The online conference will hold discussions on key clinical attributes of biosimilars, perspectives from different stakeholders regarding opportunities for the biosimilar market, and how intense can the competition get.
The conference will also address the perspective on the global regulatory landscape and how partnerships can highly support R&D and the production of biosimilars.
Witness discussions on the importance of market access and marketing strategy and how should companies enhance their presence in the market.